RU2018129024A - Альфа-цепь высокоаффинного рецептора ige (fceria) - Google Patents

Альфа-цепь высокоаффинного рецептора ige (fceria) Download PDF

Info

Publication number
RU2018129024A
RU2018129024A RU2018129024A RU2018129024A RU2018129024A RU 2018129024 A RU2018129024 A RU 2018129024A RU 2018129024 A RU2018129024 A RU 2018129024A RU 2018129024 A RU2018129024 A RU 2018129024A RU 2018129024 A RU2018129024 A RU 2018129024A
Authority
RU
Russia
Prior art keywords
fceria
ige
lysine
allergic
disease
Prior art date
Application number
RU2018129024A
Other languages
English (en)
Russian (ru)
Other versions
RU2018129024A3 (cg-RX-API-DMAC10.html
Inventor
Оскар СМРЗКА
Марва МОСТАГЕР
Original Assignee
Аффирис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аффирис Аг filed Critical Аффирис Аг
Publication of RU2018129024A publication Critical patent/RU2018129024A/ru
Publication of RU2018129024A3 publication Critical patent/RU2018129024A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
RU2018129024A 2016-01-13 2017-01-13 Альфа-цепь высокоаффинного рецептора ige (fceria) RU2018129024A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16020009.3 2016-01-13
EP16020009.3A EP3192806A1 (en) 2016-01-13 2016-01-13 Alpha chain of the high-affinity ige receptor (fceria)
PCT/EP2017/050646 WO2017121842A1 (en) 2016-01-13 2017-01-13 Alpha chain of the high-affinity ige receptor (fceria)

Publications (2)

Publication Number Publication Date
RU2018129024A true RU2018129024A (ru) 2020-02-13
RU2018129024A3 RU2018129024A3 (cg-RX-API-DMAC10.html) 2020-05-29

Family

ID=55357837

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018129024A RU2018129024A (ru) 2016-01-13 2017-01-13 Альфа-цепь высокоаффинного рецептора ige (fceria)

Country Status (8)

Country Link
US (1) US20190127438A1 (cg-RX-API-DMAC10.html)
EP (2) EP3192806A1 (cg-RX-API-DMAC10.html)
JP (1) JP2019510737A (cg-RX-API-DMAC10.html)
CN (1) CN108473551A (cg-RX-API-DMAC10.html)
AU (1) AU2017207854A1 (cg-RX-API-DMAC10.html)
CA (1) CA3010982A1 (cg-RX-API-DMAC10.html)
RU (1) RU2018129024A (cg-RX-API-DMAC10.html)
WO (1) WO2017121842A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7780186B2 (ja) 2018-10-29 2025-12-04 コデクシス， インコーポレイテッド 操作されたｄｎａポリメラーゼバリアント
CN111100210B (zh) * 2019-01-30 2022-04-19 武汉九州钰民医药科技有限公司 一种Fc融合蛋白及其应用
EP3711772A1 (en) 2019-03-20 2020-09-23 Oslo Universitetssykehus HF Recombinant proteins and fusion proteins
MX2022000285A (es) 2019-07-08 2022-02-03 Gi Innovation Inc Dimero de polipeptido con alto contenido de acido sialico, que comprende el dominio extracelular de la subunidad alfa del receptor fc de ige y composicion farmaceutica que comprende el mismo.
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒
FR3108515B1 (fr) * 2020-03-26 2022-03-25 Ct Hospitalier Universitaire Toulouse Colonne d’aphérèse pour le traitement de la polyarthrite rhumatoïde
KR102468170B1 (ko) * 2020-07-17 2022-11-17 (주)지아이이노베이션 ＩｇＥ Ｆｃ 수용체 알파서브유닛의 세포외 도메인 및 항-IL-4R 항체를 포함하는 융합단백질 및 이의 용도
JP2026511640A (ja) * 2023-03-29 2026-04-14 グリフォルス・ワールドワイド・オペレーションズ・リミテッド ＦｃεＲＩβ自己抗体のレベルが低減された血漿製剤の組成物および調製方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770774A (en) 1985-09-19 1988-09-13 Toray Industries, Inc. Column for removing β2 -microglobulin
US5985599A (en) 1986-05-29 1999-11-16 The Austin Research Institute FC receptor for immunoglobulin
US4962035A (en) 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
AU691297B2 (en) 1994-05-13 1998-05-14 Miltenyi Biotec Gmbh Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
IL116436A (en) * 1995-12-18 2006-12-31 Yissum Res Dev Co Fc?Á-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES AND
AR008077A1 (es) 1996-07-26 1999-12-09 Talarico Salinas Laura Beatriz Un polipeptido de fusion o una sal del mismo, su uso, un proceso para prepararlos, una composicion farmaceutica que los comprende, y un vector.
GB9715387D0 (en) 1997-07-23 1997-09-24 Gould Hannah J Immunoglobulin-binding polypeptides and their use
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
EP1006183A1 (en) 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
CA2385778A1 (en) * 1999-09-21 2001-03-29 Isis Innovation Limited Modulation of ige receptor cell surface expression
AU2001273456A1 (en) * 2000-07-13 2002-01-30 Hyseq, Inc. Soluble immunoglobulin e receptor alpha like molecules
US8354109B2 (en) 2005-12-13 2013-01-15 Suppremol Gmbh Multimeric Fc receptor polypeptides
WO2012140214A1 (en) 2011-04-13 2012-10-18 Biomay Ag IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
CN102660569B (zh) 2012-04-21 2013-11-06 大连理工大学 一种重组人IgE受体蛋白的制备方法及应用

Also Published As

Publication number Publication date
CA3010982A1 (en) 2017-07-20
WO2017121842A1 (en) 2017-07-20
US20190127438A1 (en) 2019-05-02
EP3402813A1 (en) 2018-11-21
AU2017207854A1 (en) 2018-06-07
CN108473551A (zh) 2018-08-31
JP2019510737A (ja) 2019-04-18
EP3192806A1 (en) 2017-07-19
RU2018129024A3 (cg-RX-API-DMAC10.html) 2020-05-29

Similar Documents

Publication Publication Date Title
JP2019510737A5 (cg-RX-API-DMAC10.html)
ES2908203T3 (es) Anticuerpos anti-age para el tratamiento de inflamación y trastornos autoinmunes
Zhou et al. Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyperresponsiveness and inflammation
Hernandez‐Santana et al. Current perspectives on the interleukin‐1 family as targets for inflammatory disease
Haynes et al. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist
Khan et al. Complement components as potential therapeutic targets for asthma treatment
BRPI0513798A (pt) anticorpos anti-cd154
US10144776B2 (en) Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
RU2012156938A (ru) Антитела против gdf8 человека
Rangel-Santos et al. Immunosuppresive role of principal toxin (crotoxin) of Crotalus durissus terrificus venom
Pandjaitan et al. Escherichia coli expression and purification of recombinant dog albumin, a cross-reactive animal allergen
Rauter et al. Mast cell–derived proteases control allergic inflammation through cleavage of IgE
EP3192806A1 (en) Alpha chain of the high-affinity ige receptor (fceria)
TW201125582A (en) Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions
JP5421116B2 (ja) 治療及び診断用ペプチド
CN116997350A (zh) 眼镜蛇科蛇突触后神经毒素单体分子在治疗老年痴呆上的应用
Prescott et al. Hypersensitivity to airborne spitting cobra snake venom
RU2010126590A (ru) Новые аллергены пшеницы
WO2018223118A1 (en) Use of tetranectin and peptide agonists to treat inflammatory diseases
JP5635771B2 (ja) 抗炎症性及び抗アレルギー性環状ペプチド
JP5937970B2 (ja) 新規ヒノキ花粉アレルゲン
TWI710569B (zh) 新穎美洲室塵蟎蛋白質
Mayer et al. New fraternine analogues: Evaluation of the antiparkinsonian effect in the model of Parkinson's disease
JP5123858B2 (ja) ＩｇＥに結合する薬剤
Chung et al. IgE binding to peanut allergens is inhibited by combined D-aspartic and D-glutamic acids

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20201111